At the American Diabetes Association annual meeting, findings from the SURPASS-EARLY trial added to growing evidence that ...

Diabetes is a serious health condition in which the body has trouble controlling blood sugar levels. This occurs because the body does not make enough insulin, does not use insulin properly or both.

Game-changing new medications called GLP-1 agonists and SGLT2 inhibitors can not only control blood sugar but also help people lose weight by making them feel full faster, so they eat less. Why is ...

Awiqli, the world's first weekly insulin, simplifies diabetes management by reducing daily injections while improving ...

Two UAB Comprehensive Diabetes Center (UCDC) members are winners of the 2025 Dean's Excellence Awards for Faculty from the UAB Heersink School of Medicine. The UAB Division of Endocrinology, Diabetes, ...

Unlocking the potential of renewable β cells and precision gene editing, researchers aim to revolutionize diabetes care and bring us closer to a functional cure for type 1 diabetes. Review Article: ...

Recognition of type 5 diabetes followed a 70-year trajectory from “J-type” reports to renewed IDF-led consensus, with formal diagnostic criteria and treatment guidelines anticipated in 2026.

Drugs approved for diabetes and obesity might be useful for the treatment of cognitive and mental health disorders, according to a new paper published in Nature Mental Health. Researchers from the ...

NewcelX ( (NCEL)) has shared an update. On July 1, 2026, NewcelX announced it had completed a successful Type B Pre-IND meeting with the U.S. Food and Drug Administration, securing constructive ...